Skip to main content
. 2021 Sep 11;10(9):1101. doi: 10.3390/antibiotics10091101

Figure 1.

Figure 1

Percentage of adherent ETEC cells on IPEC-J2 intestinal cells pre-treated or not with different doses of SB CNCM I-1079. The concentration of ETEC adherent cells on control IPEC-J2 cells (non-treated with SB yeasts) was normalized to 100% (n = 3). The denominations e6, e7, and e8, respectively, correspond to the doses of 106, 107, and 108 CFU/well of SB incubated on the ETEC-challenged IPEC-J2 cells (p value codes: *** <0.000).